Marshall Wace’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Marshall Wace’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-49,146	Closed	-$1.03M	–	1247
2016 Q3	$1.03M	Sell	49,146 -69,809	-59%	-$804K	0.01%	716
2016 Q2	$1.28M	Sell	118,955 -9,792	-8%	-$83.7K	0.01%	675
2016 Q1	$854K	Buy	+128,747	New	+$1.17M	0.01%	749
2014 Q4	–	Sell	-74,568	Closed	-$569K	–	1095
2014 Q3	$569K	Buy	+74,568	New	+$580K	0.01%	628

Marshall Wace's VTAE Position: Q4 2016 in Review

Marshall Wace sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 49,146 shares — an estimated $1.03M sold.

Marshall Wace first reported a position in VTAE in Q3 2014 and held it in 4 quarters. The position peaked at $1.28M in Q2 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Marshall Wace reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Marshall Wace sold 49,146 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.03M.
Marshall Wace first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 4 quarters.
Marshall Wace's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.28M in Q2 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.